Literature DB >> 7479688

Engineering ribonuclease A: production, purification and characterization of wild-type enzyme and mutants at Gln11.

S B delCardayré1, M Ribó, E M Yokel, D J Quirk, W J Rutter, R T Raines.   

Abstract

Bovine pancreatic ribonuclease A (RNase A) has been the object of much landmark work in biological chemistry. Yet the application of the techniques of protein engineering to RNase A has been limited by problems inherent in the isolation and heterologous expression of its gene. A cDNA library was prepared from cow pancreas, and from this library the cDNA that codes for RNase A was isolated. This cDNA was inserted into expression plasmids that then directed the production of RNase A in Saccharomyces cerevisiae (fused to a modified alpha-factor leader sequence) or Escherichia coli (fused to the pelB signal sequence). RNase A secreted into the medium by S.cerevisiae was an active but highly glycosylated enzyme that was recoverable at 1 mg/l of culture. RNase A produced by E.coli was in an insoluble fraction of the cell lysate. Oxidation of the reduced and denatured protein produced active enzyme which was isolated at 50 mg/l of culture. The bacterial expression system is ideal for the large-scale production of mutants of RNase A. This system was used to substitute alanine, asparagine or histidine for Gln11, a conserved residue that donates a hydrogen bond to the reactive phosphoryl group of bound substrate. Analysis of the binding and turnover of natural and synthetic substrates by the wild-type and mutant enzymes shows that the primary role of Gln11 is to prevent the non-productive binding of substrate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479688     DOI: 10.1093/protein/8.3.261

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  35 in total

1.  Pressure versus temperature unfolding of ribonuclease A: an FTIR spectroscopic characterization of 10 variants at the carboxy-terminal site.

Authors:  J Torrent; P Rubens; M Ribó; K Heremans; M Vilanova
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

2.  Creation of a zymogen.

Authors:  Parit Plainkum; Stephen M Fuchs; Suthep Wiyakrutta; Ronald T Raines
Journal:  Nat Struct Biol       Date:  2003-02

3.  Minor folding defects trigger local modification of glycoproteins by the ER folding sensor GT.

Authors:  Christiane Ritter; Katharina Quirin; Michael Kowarik; Ari Helenius
Journal:  EMBO J       Date:  2005-04-14       Impact factor: 11.598

4.  Enzymatic properties of newly found green turtle egg white ribonuclease.

Authors:  Somporn Katekaew; Takao Torikata; Hideki Hirakawa; Satoru Kuhara; Tomohiro Araki
Journal:  Protein J       Date:  2007-02       Impact factor: 2.371

5.  The CXXC motif: imperatives for the formation of native disulfide bonds in the cell.

Authors:  P T Chivers; M C Laboissière; R T Raines
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

6.  Gateway vectors for the production of combinatorially-tagged His6-MBP fusion proteins in the cytoplasm and periplasm of Escherichia coli.

Authors:  Sreedevi Nallamsetty; Brian P Austin; Kerri J Penrose; David S Waugh
Journal:  Protein Sci       Date:  2005-12       Impact factor: 6.725

7.  Genetic selection reveals the role of a buried, conserved polar residue.

Authors:  R Jeremy Johnson; Shawn R Lin; Ronald T Raines
Journal:  Protein Sci       Date:  2007-08       Impact factor: 6.725

8.  A hinge region cis-proline in ribonuclease A acts as a conformational gatekeeper for C-terminal domain swapping.

Authors:  Katherine H Miller; Jessica R Karr; Susan Marqusee
Journal:  J Mol Biol       Date:  2010-05-13       Impact factor: 5.469

9.  Secretory ribonucleases are internalized by a dynamin-independent endocytic pathway.

Authors:  Marcia C Haigis; Ronald T Raines
Journal:  J Cell Sci       Date:  2003-01-15       Impact factor: 5.285

10.  Ribonuclease A variants with potent cytotoxic activity.

Authors:  P A Leland; L W Schultz; B M Kim; R T Raines
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.